000048452 001__ 48452 000048452 005__ 20240122154813.0 000048452 0247_ $$2doi$$a10.1186/1758-5996-6-135 000048452 0248_ $$2sideral$$a94403 000048452 037__ $$aART-2014-94403 000048452 041__ $$aeng 000048452 100__ $$0(orcid)0000-0003-1444-7949$$aVidal Peracho, Concepción 000048452 245__ $$aA descriptive study of health status and quality of life in selected outpatients with type 2 diabetes, pathological body mass index and cardiovascular risk in Spain. 000048452 260__ $$c2014 000048452 5060_ $$aAccess copy available to the general public$$fUnrestricted 000048452 5203_ $$aBackground: Ottawa Charter defined health as a resource for everyday life and as an important dimension of health related quality of life (HRqol). Diabetes and obesity have repeatedly been shown as diseases that diminish health status and HRqol. The aim of this study was to measure health status and HRqol in a Spanish sample of obese patients with type 2 diabetes at cardiovascular risk and analyze behavioural, biological and social determinants of health. Methods: Outpatients from external specialized clinic in Endocrinology were evaluated. Measurements: sex, age, family history, employment status, comorbidities, pain, lifestyle habits, anthropometrics, blood pressure, blood analysis and HRqol with COOP/WONCA questionnaire (7 dimensions). Statistics: univariate, bivariate, multivariate and comparative analysis. Results: Mean age was 59.1 ± 7.6 [95%IC: 56.6-61.6], 74% were women and 63.2% were physically active. WONCA values were; summary index (SI): 18.7 ± 4 [95%IC: 17.3-20] (maximum 35); physical fitness: 3.3 ± 1, feelings: 2.3 ± 1.1, social activities: 1.5 ± 1, daily activities: 2.1 ± 1.2, change in health: 2.7 ± 0.9, overall health: 3.6 ± 0.7 and pain: 3.5 ± 1.2 (maximum 5). High fibrinogen values (339.3 ± 85.8 [95%IC: 309.8-368.8]) negatively influenced pain visual analogic scale (p = 0.029). Physically active patients (63.2%) had better values in daily activities dimension (p = 0.025). More than the half of the sample (51.5%) reported a good quality of sleep, but the pain worsened it (p = 0.040). High BMI values (34.8 ± 5.8 [95%IC: 32.9-36.7]) harmed the COOP-WONCA SI (p = 0.009). High glycated hemoglobin (HbA1c) values (6.8 ± 1.3 [95%IC: 6.3-7.2]) had a negative impact on COOP-WONCA SI (p = 0.018). Nor tailored diet (15.8%) or being employed (18.4%) influenced the HRqol. The regression that best models COOP-WONCA SI was adjusted for BMI and HbA1c. SI = 3.509 + 0.335BMI +0.330HbA1c. Conclusions: HRqol was worse than in general population, but better than in previous studies of diabetes patients, without differences by sex or age, though feelings, daily activities and pain dimensions scored worse than in these studies. Higher levels of HbA1c, obesity and procoagulative state had a negative impact in these last dimensions. Pain impaired quality of sleep and physical activity had a positive impact in daily activities. BMI and HbA1c modeled the HRqol. Keywords: Diabetes mellitus, Type 2, Obesity, Cardiovascular risk, Health related quality of life, Health status 000048452 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/ 000048452 590__ $$a2.173$$b2014 000048452 591__ $$aENDOCRINOLOGY & METABOLISM$$b82 / 128 = 0.641$$c2014$$dQ3$$eT2 000048452 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000048452 700__ $$0(orcid)0000-0002-9930-3903$$aLucha López, María Orosia$$uUniversidad de Zaragoza 000048452 700__ $$0(orcid)0000-0002-8399-130X$$aLucha López, Ana Carmen$$uUniversidad de Zaragoza 000048452 700__ $$0(orcid)0000-0002-3583-5206$$aTricás Moreno, José Miguel$$uUniversidad de Zaragoza 000048452 700__ $$0(orcid)0000-0002-5161-7479$$aEstébanez De Miguel, Elena$$uUniversidad de Zaragoza 000048452 700__ $$0(orcid)0000-0002-6408-5328$$aBernués Vázquez, Luis Máximo$$uUniversidad de Zaragoza 000048452 7102_ $$11006$$2255$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Enfermería 000048452 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia 000048452 773__ $$g6 (2014), 135$$pDIABETOLOGY & METABOLIC SYNDROME$$tDIABETOLOGY & METABOLIC SYNDROME$$x1758-5996 000048452 8564_ $$s783806$$uhttps://zaguan.unizar.es/record/48452/files/texto_completo.pdf$$yVersión publicada 000048452 8564_ $$s99640$$uhttps://zaguan.unizar.es/record/48452/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000048452 909CO $$ooai:zaguan.unizar.es:48452$$particulos$$pdriver 000048452 951__ $$a2024-01-22-15:30:46 000048452 980__ $$aARTICLE